Secondary Mutations M36I and A71V in the Human Immunodeficiency Virus Type 1 Protease Can Provide an Advantage for the Emergence of the Primary Mutation D30N†

José C. Clemente; Reena Hemrajani; Lisa E. Blum; Maureen M. Goodenow; Ben M. Dunn

doi:10.1021/bi035701y

Secondary Mutations M36I and A71V in the Human Immunodeficiency Virus Type 1 Protease Can Provide an Advantage for the Emergence of the Primary Mutation D30N†

Biochemistry ◽

10.1021/bi035701y ◽

2003 ◽

Vol 42 (51) ◽

pp. 15029-15035 ◽

Cited By ~ 39

Author(s):

José C. Clemente ◽

Reena Hemrajani ◽

Lisa E. Blum ◽

Maureen M. Goodenow ◽

Ben M. Dunn

Keyword(s):

Human Immunodeficiency Virus ◽

Human Immunodeficiency Virus Type ◽

Virus Type ◽

Primary Mutation ◽

Immunodeficiency Virus

Download Full-text

Use of Dried Spots of Whole Blood, Plasma, and Mother's Milk Collected on Filter Paper for Measurement of Human Immunodeficiency Virus Type 1 Burden

Yearbook of Pathology and Laboratory Medicine ◽

10.1016/s1077-9108(08)70752-7 ◽

2008 ◽

Vol 2008 ◽

pp. 351-352

Author(s):

M.G. Bissell

Keyword(s):

Human Immunodeficiency Virus ◽

Blood Plasma ◽

Human Immunodeficiency Virus Type ◽

Virus Type ◽

Filter Paper ◽

Whole Blood ◽

Immunodeficiency Virus ◽

Mother's Milk ◽

Mother’S Milk

Download Full-text

Detection of human immunodeficiency virus type 1 and human papillomavirus type 16 in acquired immunodeficiency syndrome-related and classic Kaposi's sarcoma

Archives of Dermatology ◽

10.1001/archderm.129.12.1620 ◽

1993 ◽

Vol 129 (12) ◽

pp. 1620-1622 ◽

Cited By ~ 1

Author(s):

H. Fujiwara

Keyword(s):

Human Immunodeficiency Virus ◽

Human Papillomavirus ◽

Human Immunodeficiency Virus Type ◽

Virus Type ◽

Acquired Immunodeficiency Syndrome ◽

Human Papillomavirus Type 16 ◽

Immunodeficiency Virus ◽

Acquired Immunodeficiency ◽

Immunodeficiency Syndrome

Download Full-text

LONGITUDINAL ANALYSIS OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 RNA IN BREAST MILK AND OF ITS RELATIONSHIP TO INFANT INFECTION AND MATERNAL DISEASE

PEDIATRICS ◽

10.1542/peds.114.2.s1.552-a ◽

2004 ◽

Vol 114 (2) ◽

pp. 552-552

Author(s):

J. A. Church

Keyword(s):

Human Immunodeficiency Virus ◽

Breast Milk ◽

Human Immunodeficiency Virus Type ◽

Virus Type ◽

Longitudinal Analysis ◽

Immunodeficiency Virus ◽

Maternal Disease

Download Full-text

Human Immunodeficiency Virus Type 1 Pharmacogenomics in Clinical Practice: Relevance of HIV-1 Drug Resistance Testing (Part 2)

Journal of Environmental Pathology Toxicology and Oncology ◽

10.1615/jenvpathtoxoncol.v22.i4.20 ◽

2003 ◽

Vol 22 (4) ◽

pp. 281-286 ◽

Cited By ~ 1

Author(s):

Martha S. Bianchi ◽

Alejandro D. Bolzan

Keyword(s):

Human Immunodeficiency Virus ◽

Drug Resistance ◽

Clinical Practice ◽

Human Immunodeficiency Virus Type ◽

Virus Type ◽

Resistance Testing ◽

Drug Resistance Testing ◽

Immunodeficiency Virus ◽

Hiv 1

Download Full-text

Abnormal biomarkers of Liver Function in Human Immunodeficiency Virus type 1 infected Subjects without Hepatitis B or C co-infection and their Association with Disease Severity

Journal of Medical Discovery ◽

10.24262/jmd.3.1.17058 ◽

2017 ◽

Vol 3 (1) ◽

Author(s):

Mathias Abiodun Emokpae ◽

◽

Joy Oseluese Akhimien

Keyword(s):

Human Immunodeficiency Virus ◽

Hepatitis B ◽

Liver Function ◽

Disease Severity ◽

Human Immunodeficiency Virus Type ◽

Virus Type ◽

Immunodeficiency Virus

Download Full-text

A Study to Assess Effectiveness and Safety of Fixed Dose Combination of Lopinavir/Ritonavir (LPV/r) in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Patients After Switching From Kaletra in the Routine Clinical Settings of Russian Federation

Case Medical Research ◽

10.31525/ct1-nct04138199 ◽

2019 ◽

Author(s):

Keyword(s):

Human Immunodeficiency Virus ◽

Human Immunodeficiency Virus Type ◽

Virus Type ◽

Russian Federation ◽

Fixed Dose ◽

Clinical Settings ◽

Immunodeficiency Virus ◽

Dose Combination ◽

Hiv 1

Download Full-text

Faculty Opinions recommendation of Higher baseline levels of plasma human immunodeficiency virus type 1 RNA are associated with increased mortality after initiation of triple-drug antiretroviral therapy.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1005200.200428 ◽

2003 ◽

Author(s):

Luis J Montaner

Keyword(s):

Human Immunodeficiency Virus ◽

Antiretroviral Therapy ◽

Human Immunodeficiency Virus Type ◽

Virus Type ◽

Immunodeficiency Virus ◽

Baseline Levels

Download Full-text

Faculty Opinions recommendation of Death of CD4(+) T-cell lines caused by human immunodeficiency virus type 1 does not depend on caspases or apoptosis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1005863.106959 ◽

2002 ◽

Author(s):

Christoph Borner

Keyword(s):

Human Immunodeficiency Virus ◽

T Cell ◽

Cell Lines ◽

Human Immunodeficiency Virus Type ◽

Virus Type ◽

Cd4 T Cell ◽

Immunodeficiency Virus ◽

T Cell Lines

Download Full-text

Faculty Opinions recommendation of Comprehensive screening reveals strong and broadly directed human immunodeficiency virus type 1-specific CD8 responses in perinatally infected children.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1015434.196855 ◽

2003 ◽

Author(s):

Luis J Montaner

Keyword(s):

Human Immunodeficiency Virus ◽

Human Immunodeficiency Virus Type ◽

Virus Type ◽

Immunodeficiency Virus ◽

Perinatally Infected

Download Full-text

Faculty Opinions recommendation of In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1040768.489808 ◽

2006 ◽

Author(s):

Jonathan Schapiro

Keyword(s):

Human Immunodeficiency Virus ◽

Human Immunodeficiency Virus Type ◽

Virus Type ◽

Immunodeficiency Virus ◽

Maturation Inhibitor

Download Full-text